Early aggressive treatment in patients whose cancer is likely to progress slowly, if at all, causes side-effects and reduces their quality of life for no benefit. Can active surveillance avoid this?
Related Articles
Cutting Edge
Don’t shoot the driver! It’s about taxonomy more than targets
Editorial
Prostate cancer screening: a question of common sense
Spotlight on
Leave a Reply